Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Endometriosis Treatment Market Share, Size, Growth, Analysis, Forecast: By Indication Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Others; By Diagnostic Method: Ultrasound, Others; By Therapeutics Method; By Drug Class; By Distribution Channel; Regional Analysis; Supplier Landscape; 2023-2031
Global Endometriosis Treatment Market Outlook
The global endometriosis treatment market size was estimated to be worth USD 1.44 billion in 2022. The market is expected to grow at a CAGR of 7.7% during the forecast period of 2023-2031 to attain a market value of USD 2.79 billion by 2031. The growth of the market is driven by the rising research and development activities.
Introduction
Endometriosis refers to the chronic disease that affects the women of reproductive age, more than 10% of the women suffer from the disease across the globe. The current treatments often just provide temporary solutions, and the disease recurs as soon as the patient stops taking the medicines. Endometriosis refers to the condition where a tissue, which is similar to the uterus lining, grows on the other parts of the body. This can lead to discomfort and other serious issues that can affect the daily routine of the patient. The common areas where endometriosis can develop include fallopian tubes, vagina, ovaries, diaphragm, bladder, intestines, ureters, and peritoneum.
Endometriosis is common in the age group of 25-40 years and can also affect the younger generation during their teenage years. The exact cause of endometriosis is still unclear; however, it is associated with several risk factors, including genetic and environmental factors.
The common signs and symptoms of endometriosis include pain and inflammation, which can be mild or intense. This pain is felt in the abdomen, lower back, and pelvic region, mainly affecting the lower half of the patient’s body. The other symptoms of this disease are painful menstrual cramps, difficult bowel movements, irregular periods, abdominal pain, and infertility.
The early diagnosis of endometriosis is essential for proper and effective treatment. Physical examination and pelvic exams are among the preliminary tests used for diagnosing the disease. Tests like MRI and laproscopy are also done to confirm the presence and severity of endometriosis.
There are different therapeutic interventions available for the management of the endometriosis, which includes hormonal options, oral medications, and other surgical methods. The anti-inflammatory medications aid in the alleviation of the pain related symptoms and thus provide relief to the patient.
Hormonal options help in the balancing of the abnormal hormonal levels, which lead to the less painful and normal menstrual periods. In case of chronic condition, surgery is recommended to remove the lesions and the extra tissue growth responsible for causing the chronic symptoms.
According to this study, the endometriosis treatment market can be categorised into the following segments:
Market Breakup by Indication Type
- Superficial Peritoneal Lesion
- Endometrioma
- Deeply Infiltrating Endometriosis
- Others
Market Breakup by Diagnostic Method
- Ultrasound
- Pelvic Examination
- Laparoscopy
- Magnetic Resonance Imaging
- Others
Market Breakup by Treatment Method
- Hormonal Therapy
- Pain Management
- Others
Endometriosis Treatment Market Breakup by Drug Class
- Oral Contraceptives
- Progestins
- NSAIDs
- GnRH Analogues
- Others
Market Breakup by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Endometriosis Treatment Market Scenario
The growth of the endometriosis treatment market is primarily driven by the rising prevalence of the gynaecological and endometriosis ailments, among other chronic diseases. This has aided the demand for hormonal therapies and anti-inflammatory medications, leading to the growth of the global market during the forecast period.
According to the World Health Organisation, in 2021, nearly 190 million reproductive women were diagnosed with endometriosis all over the world. The prevalence of the disease is expected to rise further during the forecast years with the growing population and rising adoption of the sedentary lifestyle habits.
Furthermore, the public and private sectors are investing in the healthcare infrastructure, which is projected to enhance the diagnostic and therapeutic options. The availability of patient assistance and rehabilitation programs for expensive medications is estimated to fuel the endometriosis treatment market development.
With the extensive research and development, there is the invention of the novel advanced drug delivery technologies, which aid the optimisation of the normal hormonal levels. For example, Noven has discovered a novel CombiPatch, a two-drug patch that is anticipated to propel the endometriosis treatment market development.
North America is expected to dominate the endometriosis treatment market owing to the higher incidence of endometriosis and other gynaecological disorders in this region. This has led to increased demand for hormone therapeutics and is also attracting the interests of the market players toward this sector.
Therapeutic Landscape of the Endometriosis Treatment Market
The treatment for the endometriosis depends on the cumulative effect of several factors, such as the age of patient, the severity of the symptoms, and the plans for future pregnancies. The recent developments in the market are as follows:
Hormonal Treatment: The first line treatment for the condition includes non-steroidal anti-inflammatory drugs, combined oral contraceptives (COCs) or progestin. Hormonal treatments are still considered as a suppressive measure and not curative. These hormonal treatments work by lowering or suppressing local or systemic estrogen levels. Following this, the second line treatment consists of GnRH agonists that brings down the estrogen levels to post-menopausal concentrations. The hormonal treatments include Progestins, GnRH agonists, GnRH antagonists, dopamine agonists, selective estrogen receptor modulators, and selective progesterone receptor modulators.
Non-Hormonal Treatment: This methos includes the treatment of angiogenesis, fibrosis, inflammatory cytokines and immune cells, stem cells, migration of endometrial cells, and apoptosis, among others.
Recent Advancements in the Market:
Consensus on CO2 Laser Excision Surgery: Endoscopic CO2 laser excision of endometriosis helps see the lesions more clearly, making it easier for the physician to remove the lesion while ensuring that the underlying tissue is preserved. The treatment of endometriosis is critical because it adheres to the sciatic nerves, ovaries, ureters, the bowel, the peritoneum, and other delicate structures, and it extremely important that the treatment is done carefully.
Pelvic Floor Physical Therapy: This therapy can help reduce the symptoms of endometriosis like painful sex and pelvic pain. It can also improve the pelvic relaxation in women suffering from the disease.
The market has been witnessing significant advancements and is likely to witness many more in the coming years owing to the rising prevalence of the disease.
Competitive Landscape of the Endometriosis Treatment Market
The report gives an in-depth analysis of the key players involved in the endometriosis treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
- Abbott
- AbbVie Inc.
- Bayer AG
- Pfizer Inc.
- Ipsen Pharma
- Evotec SE
- Myovant Sciences GmbH
- Philogen S.p.A.
- Astellas Pharma Inc.
- Orphagen Pharmaceuticals
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2016-2022 |
| Forecast Period | 2023-2031 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Indication Type |
|
| Breakup by Diagnostic Method |
|
| Breakup by Therapeutics Method |
|
| Breakup by Drug Class |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.1.1 Research Objectives
1.1.2 Key Findings of the Report
1.2 Limitations of the Study and Scope for Future Research
2 Research Methodology
3 Executive Summary
4 Global Endometriosis Overview
4.1 Guidelines and Stages
4.2 Pathophysiology
4.3 Screening and Diagnosis
4.4 Treatment Pathway
5 Patient Profile
5.1 Patient Profile Overview
5.2 Patient Psychology and Emotional Impact Factors
5.3 Risk Assessment and Treatment Success Rate
6 Global Endometriosis Treatment Market
6.1 Global Endometriosis Treatment Market Overview
6.2 Global Endometriosis Treatment Market Analysis
6.2.1 Market Overview
6.2.1.1 Global Endometriosis Treatment Market Historical Value (2016-2022)
6.2.1.2 Global Endometriosis Treatment Market Forecast Value (2023-2031)
6.2.2 Global Endometriosis Treatment Market by Indication Type
6.2.2.1 Market Overview
6.2.2.1.1 Superficial Peritoneal Lesion
6.2.2.1.2 Endometrioma
6.2.2.1.3 Deeply Infiltrating Endometriosis
6.2.2.1.4 Others
6.2.3 Global Endometriosis Treatment Market by Diagnostic Method
6.2.3.1 Market Overview
6.2.3.1.1 Ultrasound
6.2.3.1.2 Pelvic Examination
6.2.3.1.3 Laparoscopy
6.2.3.1.4 Magnetic Resonance Imaging
6.2.3.1.5 Others
6.2.4 Global Endometriosis Treatment Market by Therapeutics Method
6.2.4.1 Market Overview
6.2.4.1.1 Hormonal Therapy
6.2.4.1.2 Pain Management
6.2.4.1.3 Others
6.2.5 Global Endometriosis Treatment Market by Drug Class
6.2.5.1.1 Oral Contraceptives
6.2.5.1.2 Progestins
6.2.5.1.3 NSAIDs
6.2.5.1.4 GnRH Analogues
6.2.5.1.5 Others
6.2.6 Global Endometriosis Treatment Market by Distribution Channel
6.2.6.1 Market Overview
6.2.6.1.1 Hospital Pharmacies
6.2.6.1.2 Retail Pharmacies
6.2.6.1.3 Online Pharmacies
6.2.7 Global Endometriosis Treatment Market by Region
6.2.7.1 Market Overview
6.2.7.1.1 North America
6.2.7.1.1.1 Historical Trend (2016-2022)
6.2.7.1.1.2 Forecast Trend (2023-2031)
6.2.7.1.2 Europe
6.2.7.1.2.1 Historical Trend (2016-2022)
6.2.7.1.2.2 Forecast Trend (2023-2031)
6.2.7.1.3 Asia Pacific
6.2.7.1.3.1 Historical Trend (2016-2022)
6.2.7.1.3.2 Forecast Trend (2023-2031)
6.2.7.1.4 Latin America
6.2.7.1.4.1 Historical Trend (2016-2022)
6.2.7.1.4.2 Forecast Trend (2023-2031)
6.2.7.1.5 Middle East and Africa
6.2.7.1.5.1 Historical Trend (2016-2022)
6.2.7.1.5.2 Forecast Trend (2023-2031)
7 North America Endometriosis Treatment Market
7.1 United States of America
7.1.1 Historical Trend (2016-2022)
7.1.2 Forecast Trend (2023-2031)
7.2 Canada
7.2.1 Historical Trend (2016-2022)
7.2.2 Forecast Trend (2023-2031)
8 Europe Endometriosis Treatment Market
8.1 United Kingdom
8.1.1 Historical Trend (2016-2022)
8.1.2 Forecast Trend (2023-2031)
8.2 Germany
8.2.1 Historical Trend (2016-2022)
8.2.2 Forecast Trend (2023-2031)
8.3 France
8.3.1 Historical Trend (2016-2022)
8.3.2 Forecast Trend (2023-2031)
8.4 Italy
8.4.1 Historical Trend (2016-2022)
8.4.2 Forecast Trend (2023-2031)
9 Asia Pacific Endometriosis Treatment Market
9.1 China
9.1.1 Historical Trend (2016-2022)
9.1.2 Forecast Trend (2023-2031)
9.2 Japan
9.2.1 Historical Trend (2016-2022)
9.2.2 Forecast Trend (2023-2031)
9.3 India
9.3.1 Historical Trend (2016-2022)
9.3.2 Forecast Trend (2023-2031)
9.4 ASEAN
9.4.1 Historical Trend (2016-2022)
9.4.2 Forecast Trend (2023-2031)
9.5 Australia
9.5.1 Historical Trend (2016-2022)
9.5.2 Forecast Trend (2023-2031)
10 Latin America Endometriosis Treatment Market
10.1 Brazil
10.1.1 Historical Trend (2016-2022)
10.1.2 Forecast Trend (2023-2031)
10.2 Argentina
10.2.1 Historical Trend (2016-2022)
10.2.2 Forecast Trend (2023-2031)
10.3 Mexico
10.3.1 Historical Trend (2016-2022)
10.3.2 Forecast Trend (2023-2031)
11 Middle East and Africa Endometriosis Treatment Market
11.1 Saudi Arabia
11.1.1 Historical Trend (2016-2022)
11.1.2 Forecast Trend (2023-2031)
11.2 United Arab Emirates
11.2.1 Historical Trend (2016-2022)
11.2.2 Forecast Trend (2023-2031)
11.3 Nigeria
11.3.1 Historical Trend (2016-2022)
11.3.2 Forecast Trend (2023-2031)
11.4 South Africa
11.4.1 Historical Trend (2016-2022)
11.4.2 Forecast Trend (2023-2031)
12 Current Scenario Evaluation and Regulatory Framework
12.1 Emerging Therapies and Clinical Trials
12.2 Patent Landscape
12.2.1 Patent Overview
12.2.1.1 Patent Status and Expiry
12.2.1.2 Timelines from Drug Development to Commercial Launch
12.2.1.3 New Drug Application
12.2.1.3.1 Documentation and Approval Process
12.3 Cost of Treatment
12.4 Regulatory Framework
12.4.1 Regulatory Overview
12.4.1.1 US FDA
12.4.1.2 EU EMA
12.4.1.3 INDIA CDSCO
12.4.1.4 JAPAN PMDA
12.4.1.5 Others
13 Challenges & Unmet Needs
13.1 Treatment Pathway Challenges
13.2 Compliance and Drop-Out Analysis
13.3 Awareness and Prevention Gaps
14 Global Endometriosis Treatment Market Dynamics
14.1 Market Drivers and Constraints
14.2 SWOT Analysis
14.3 Porter’s Five Forces Model
14.4 Key Demand Indicators
14.5 Key Price Indicators
14.6 Industry Events, Initiatives & Trends
14.7 Value Chain Analysis
15 Supplier Landscape
15.1 Abbott
15.1.1 Company Overview
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.1.5 Certifications
15.2 AbbVie Inc.
15.2.1 Company Overview
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Bayer AG
15.3.1 Company Overview
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Pfizer Inc.
15.4.1 Company Overview
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Ipsen Pharma
15.5.1 Company Overview
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Evotec SE
15.6.1 Company Overview
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 Myovant Sciences GmbH
15.7.1 Company Overview
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 Philogen S.p.A.
15.8.1 Company Overview
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Astellas Pharma Inc.
15.9.1 Company Overview
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Orphagen Pharmaceuticals
15.10.1 Company Overview
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
16 Recommendations and Discussion
17 Global Endometriosis Treatment Drugs Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Payment Methods (Additional Insight)
18.1 Government Funded
18.2 Private Insurance
18.3 Out-of-Pocket
*Additional insights provided are customizable as per client requirements.
Key Questions Answered in the Report
The endometriosis market attained a value of nearly USD 1.44 billion in 2022.
The market is projected to grow at a CAGR of 7.7% during the forecast period of 2023-2031.
The market is estimated to witness a healthy growth in the forecast period of 2023-2031 to reach USD 2.79 billion by 2031.
The growth of the market is driven by factors like rising cases of endometriosis due to the rising issues in women of reproductive age and the rising awareness about the disease.
The rapid advancements and developments in the market acts as a key trend for the market.
The indications of the disease include superficial peritoneal lesion, endometrioma, and deeply infiltrating endometriosis, among others.
The diagnostic methods include ultrasound, pelvic examination, laparoscopy, and magnetic resonance imaging, among others.
The treatment methods include hormonal therapy and pain management, among others.
The drugs include oral contraceptives, progestins, NSAIDs, and GnRH analogues, among others.
The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share of the market.
The key players in the market include Abbott, AbbVie Inc., Bayer AG, Pfizer Inc., Ipsen Pharma, Evotec SE, Myovant Sciences GmbH, Philogen S.p.A., Astellas Pharma Inc., and Orphagen Pharmaceuticals, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$2499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$4999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$6499-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$7999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER